top of page
Search

COVID guidelines update and Antifungal prophylaxis guidelines

The MUHC ASP committee is happy to announce the update and publication of several guidelines:

  • Pre-exposure prophylaxis to COVID : Recommended Evusheld dose is now increased to 300/300 mg

  • COVID management guidelines (minor changes)

  • COVID outpatient decision tree : inclusion of situation in which to give Evusheld

  • Antifungal prophylaxis guidelines (developed with the help of Transplant and Hematology-oncology team)

We are also proud to publish our Annual report for 2021-2022. It is now available in the section Resources of the website.


Good reading to all and happy thanksgiving!

Francois Bourdeau, ASP co-chair

 
 
 

Recent Posts

See All
MUHC ASP annual report 2024-2025

The ASP chairs are happy to publish the MUHC ASP annual report 2024-2025, now available in the Resources section of the MUHC ASP website. The report contains several key information and analysis on th

 
 
 
New guide : IV to PO

The ASP committee is happy to make available the new guide IV to PO! It covers situation in which a switch to PO is indicated for certain...

 
 
 

Comments


logo2.png

1001 Decarie Blvd, Montreal, Quebec H4A 3J1, Canada

+1 514-934-1934

bottom of page